LOUISIANA RECORD

Recent News About DLA Piper

• 

  DLA Piper advises Alimera Sciences in acquisition by ANI Pharmaceuticals

  By The Louisiana Record | Friday, Jul 5, 2024 @ 7:00am

  DLA Piper advised Alimera Sciences, Inc., a global pharmaceutical company focused on ophthalmic solutions, in its acquisition by ANI Pharmaceuticals, a diversified biopharmaceutical company, in a transaction that values Alimera at approximately US$381 million in up front consideration plus contingent value rights providing for additional consideration upon the achievement of certain revenue milestones.

  ---